Liver Function Tests Following Irreversible Electroporation of Liver Tumors: Experience in 174 Procedures

Techniques in Vascular and Interventional Radiology

Volumn 18, Issue 3, 2015, Pages 140-146

  Froud, Tatiana ^a   Venkat, Shree R ^a   Barbery, Katuzka J ^a   Gunjan, Arora ^a   Narayanan, Govindarajan ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Alanine aminotransaminase; Alkaline phosphatase; ALKP; ALT; Aspartate aminotransaminase; AST; Bilirubin; Cirrhosis; IRE; LFTs; Liver function; TBIL; Tumor; XXX SGOT; XXX SGPT

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER;

ABLATION THERAPY; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT CARCINOMA; BILIRUBIN BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTRANSAMINASEMIA; IRREVERSIBLE ELECTROPORATION; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; TUMOR ABLATION; ADVERSE EFFECTS; BLOOD; CELL DEATH; COMPUTER ASSISTED SURGERY; ELECTROPORATION; LIVER NEOPLASMS; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE; PROCEDURES; RETROSPECTIVE STUDY; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ABLATION TECHNIQUES; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BIOMARKERS; CELL DEATH; ELECTROPORATION; FEMALE; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; ORGAN SIZE; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURGERY, COMPUTER-ASSISTED; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84941274241     PISSN: 10892516     EISSN: 15579808     Source Type: Journal    
DOI: 10.1053/j.tvir.2015.06.004     Document Type: Article

References (7)

1. Jiang C., Davalos R.V., Bischof J.C. A review of basic to clinical studies of irreversible electroporation therapy. IEEE Trans Biomed Eng 2015, 62(1):4-20.
2. Narayanan G., Bhatia S., Echenique A., et al. Vessel patency post irreversible electroporation. Cardiovasc Intervent Radiol 2014, 37(6):1523-1529.
3. Narayanan G., Froud T., Suthar R., et al. Irreversible electroporation of hepatic malignancy. Semin Interv Radiol 2013, 30(1):67-73. http://dx.doi.org/10.1055/s-0033-1333655.
4. Green R.M., Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002, 123:1367-1384.
5. Sevdenur Cizginer Servet Tatli, Shelley Hurwitz, et al. Biochemical and hematologic changes after percutaneous radiofrequency ablation of liver tumors: Experience in 83 procedures. J Vasc Interv Radiol 2011, 22:471-478.
6. Nakazawa T., Kokubu S., Shibuya A., et al. Radiofrequency ablation of hepatocellular carcinoma: Correlation between local tumor progression after ablation and ablative margin. Am J Roentgenol 2007, 188:480-488.
7. Nair R.T., Silverman S.G., Tuncali K., et al. Biochemical and hematologic alterations following percutaneous cryoablation of liver tumors: Experience in 48 procedures. Radiology 2008, 248:303-311.